Biomedical Engineering Reference
In-Depth Information
[91] Cryan, S.A., et al., “Increased intracellular targeting to airway cells using octaarginine-
coated liposomes: in vitro assessment of their suitability for inhalation,”
Mol Pharm
, Vol. 3,
No. 2, 2006, pp. 104-12.
[92] Liu, J., et al., “Nanostructured materials designed for cell binding and transduction,”
Biomacromolecules
, Vol. 2, No. 2, 2001, pp. 362-8.
[93] Becker, M.L., et al., “Peptide-derivatized shell-cross-linked nanoparticles. 1. Synthesis and
characterization,”
Bioconjug Chem
, Vol. 15, No. 4, 2004, pp. 699-709.
[94] Becker, M.L., Bailey, L.O., and Wooley, K.L., “Peptide-derivatized shell-cross-linked
nanoparticles. 2. Biocompatibility evaluation,”
Bioconjug Chem
, Vol. 15, No. 4, 2004, pp.
710-7.
[95] Santra, S., et al., “TAT conjugated, FITC doped silica nanoparticles for bioimaging
applications,”
Chem Commun (Camb)
, Vol. 24, 2004, pp. 2810-1.
[96] de la Fuente, J.M., and Berry, C.C., “Tat peptide as an efficient molecule to translocate gold
nanoparticles into the cell nucleus,”
Bioconjug Chem
, Vol. 16, No. 5, 2005, pp. 1176-80.
[97] Nativo, P., Prior, I.A., and Brust, M., “Uptake and intracellular fate of surface-modified
gold nanoparticles,”
ACS Nano
, Vol. 2, No. 8, 2008, pp. 1639-44.
[98] Zhang, K., et al., “Shape effects of nanoparticles conjugated with cell-penetrating peptides
(HIV Tat PTD) on CHO cell uptake,”
Bioconjug Chem
, Vol. 19, No. 9, 2008, pp. 1880-7.
[99] Medintz, I.L., et al., “Quantum dot bioconjugates for imaging, labelling and sensing,”
Nat
Mater
, Vol. 4, No. 6, 2005, pp. 435-46.
[100] Santra, S., et al., “Rapid and effective labeling of brain tissue using TAT-conjugated
CdS:Mn/ZnS quantum dots,”
Chem Commun (Camb)
, Vol. 25, 2005, pp. 3144-6.
[101] Chen, B., et al., “Transmembrane delivery of the cell-penetrating peptide conjugated
semiconductor quantum dots,”
Langmuir
, Vol. 24, No. 20, 2008, pp. 11866-71.
[102] Ballou, B., et al., “Noninvasive imaging of quantum dots in mice,”
Bioconjug Chem
, Vol.
15, No. 1, 2004, pp. 79-86.
[103] Silver, J., and Ou, W., “Photoactivation of quantum dot fluorescence following
endocytosis,”
Nano Lett
, Vol. 5, No. 7, 2005, pp. 1445-9.
[104] Delehanty, J.B., et al., “Self-assembled quantum dot-peptide bioconjugates for selective
intracellular delivery,”
Bioconjug Chem
, Vol. 17, No. 4, 2006, pp. 920-7.
[105] Rozenzhak, S.M., et al., “Cellular internalization and targeting of semiconductor quantum
dots,”
Chem Commun (Camb)
, Vol. 17, 2005, pp. 2217-9.
[106] Lasic, D.D.,
Liposomes: From Physics to Applications
, Amersterdam: Elsevier, 1993.
[107] Torchilin, V.P., “Recent advances with liposomes as pharmaceutical carriers,”
Nat Rev
Drug Discov
, Vol. 4, No. 2, 2005, pp. 145-60.
[108] Lasic, D.D., and Martin, F.J.,
Stealth Liposomes
, Boca Raton: CRC Press, 1995.
[109] Torchilin, V.P., et al., “Poly(ethylene glycol)-coated anti-cardiac myosin
immunoliposomes: factors influencing targeted accumulation in the infarcted myocardium,”
Biochim Biophys Acta
, Vol. 1279, No. 1, 1996, pp. 75-83.
[110] Torchilin, V.P., et al., “p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple
attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG
chains via p-nitrophenylcarbonyl groups,”
Biochim Biophys Acta
, Vol. 1511, No. 2, 2001,
pp. 397-411.
[111] Torchilin, V.P., “Structure and design of polymeric surfactant-based drug delivery
systems,”
J Control Release
, Vol. 73, No. 2-3, 2001, pp. 137-72.
[112] Torchilin, V.P., “Micellar nanocarriers: pharmaceutical perspectives,”
Pharm Res
, Vol. 24,
No. 1, 2007, pp. 1-16.
[113] Maeda, H., et al., “Tumor vascular permeability and the EPR effect in macromolecular
therapeutics: a review,”
J Control Release
, Vol. 65, No. 1-2, 2000, pp. 271-84.
Search WWH ::
Custom Search